According to this latest publication from Meticulous Research®, the Rapid Diagnostics Kits Market for Indian Ocean region countries is expected to register a CAGR of 1.6% from 2022 to 2029 to reach $1.75 billion by 2029. A rapid diagnostic test (RDT) is a medical test that provides diagnostic results expeditiously (within 1 hour). RDT kits are widely used in hospitals, clinics, and diagnostic laboratories for the qualitative and quantitative detection of specific antigens, antibodies, and markers of proteins associated with specific health conditions or human diseases. The growth of this market is driven by the growing demand for PoC diagnostics, the high prevalence of chronic diseases coupled with the increasing geriatric population, the growing prevalence of infectious diseases, the increasing need for rapid decision-making, and the outbreak of the COVID-19 pandemic. Moreover, emerging markets are expected to offer growth opportunities for the players operating in the rapid diagnostic kits market in Indian Ocean region countries.
Here are the top 10 companies operating in the Rapid Diagnostics Kits Market for Indian Ocean Region Countries
Founded in 1888 and headquartered in Illinois, U. S., Abbott Laboratories develops, manufactures, and markets a broad and diversified range of healthcare products. The company operates through four reportable business segments, namely, Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company operates in the rapid diagnostics market through its Diagnostics Products business segment. The Diagnostic Products segment offers a broad line of diagnostic systems and tests manufactured, marketed, and sold to blood banks, hospitals, commercial laboratories, clinics, physicians’ offices, retailers, government agencies, alternate care testing sites, and plasma protein therapeutic firms globally.
Abbott has its presence across various countries, including Germany, Japan, India, Switzerland, Russia, France, Brazil, Italy, the U.K., the U.S., the Netherlands, Colombia, and Vietnam. The company operates through its 92 manufacturing facilities across the globe, of which 23 are for diagnostic product manufacturing. The company has its R&D centers in the U.S., Canada, Germany, Norway, and the U.K.
Becton, Dickinson and Company (U.S.)
Founded in 1897 and headquartered in New Jersey, U.S., Becton, Dickinson and Company (BD) is a medical technology firm engaged in developing, manufacturing, and selling a broad line of medical devices, supplies, laboratory equipment, and diagnostic products. The company offers its products to healthcare institutions, life science researchers, physicians, clinics, diagnostic laboratories, and the pharmaceutical industry. BD operates through three reportable business segments, namely, BD Medical, BD Life Sciences, and BD Interventional. The BD Life Sciences segment offers products for the safe collection and transportation of diagnostic specimens, instruments, and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections, and cancers. In addition, this segment also produces research and clinical tools that promote the study of cells, and the components of cells, to acquire a better understanding of normal and disease processes. The BD Life Sciences segment consists of two organizational units: Integrated Diagnostic Solutions and Biosciences. The company operates in the rapid diagnostics market through Integrated Diagnostic Solutions, an organizational unit of the BD Life Sciences business segment.
The company has manufacturing facilities outside the U.S. in Bosnia and Herzegovina, Brazil, Canada, China, Dominican Republic, France, Germany, Hungary, India, Ireland, Italy, Japan, Mexico, the Netherlands, Singapore, Spain, and the U.K. The subsidiaries of the company operating in the rapid diagnostics market include Becton Dickinson Canada Inc., Becton Dickinson GmbH (Germany), BD Rapid Diagnostic (Suzhou) Co., Ltd. (China), Becton Dickinson Asia Limited (Hong Kong), Becton, Dickinson B.V. (Netherlands), and Becton Dickinson India Private Limited.
Bio-Rad Laboratories, Inc. (U.S.)
Founded in 1952 and headquartered in California, U.S., Bio-Rad is a manufacturer and distributor of life science research and clinical diagnostics products and systems broadly used by life science research, healthcare, and analytical chemistry, among other markets, to separate complex chemical and biological materials and identify, analyze, and purify components. The company has two reportable business segments, namely, Life Science and Clinical Diagnostics.
The company operates in the rapid diagnostics market through its Clinical Diagnostics business segment. The segment designs, manufactures, and sells test systems, informatics systems, test kits, and specialized quality controls and serves hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories as end users.
Bio-Rad has a geographical presence in over 36 countries outside the U.S. through subsidiaries. The company’s principal manufacturing and research sites are in the U.S., Singapore, the U.K., France, Belgium, Switzerland, and Germany.
F. Hoffmann-La Roche Ltd. (Switzerland)
Founded in 1896 and headquartered in Basel, Switzerland, F. Hoffmann-La Roche is a healthcare company that develops, manufactures, and markets a wide range of healthcare solutions. The company operates through two reportable business divisions, namely, Pharmaceuticals and Diagnostics. The company operates in the rapid diagnostics market through its Diagnostics division. The Diagnostics division develops a wide range of diagnostic products and solutions that include in vitro diagnostics solutions, molecular diagnostics, clinical chemistry & immunoassays, point-of-care testing, tissue diagnostics, patient self-testing, next-generation sequencing, laboratory automation and IT, and decision support solutions.
Roche has a geographical presence across the U.S., Germany, Switzerland, Japan, China, India, New Zealand, Australia, Latin America, and Africa. The company has subsidiaries across the globe to fulfill its production and sales needs. The subsidiaries of the company operating in the rapid diagnostics market include Genentech (U.S.), Roche Diagnostics (U.S.), Roche Diagnostics GmbH (Germany), Roche Diagnostics (Shanghai) Ltd. (China), Roche Diagnostics (Suzhou) Limited (China), and Roche Diagnostics K.K (Japan).
ACON Laboratories, Inc. (U.S.)
Founded in 1996 and headquartered in California, U.S., ACON manufactures and markets rapid diagnostics and healthcare products worldwide. Some of the brands offered by the company include On Call, Mission, HealthyMe, ACON, Flowflex, Distinct, Foresights, Promotor, and Centrivet. The U.S. office is the center of strategic management, business development, administration, and research & development. The company has a geographical presence in over 130 countries with ISO13485: 2016 certified manufacturing facility in Hangzhou, China.
Danaher Corporation (U.S.)
Founded in 1969 and headquartered in Washington, D.C., U.S., Danaher designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company operates through three reportable business segments, namely, Life Sciences, Diagnostics, and Environmental & Applied Solutions.
Danaher offers its rapid diagnostic kits through its subsidiaries Beckman Coulter Inc. (U.S.), Cepheid (U.S.), HemoCue AB (Sweden), and Radiometer Medical ApS (Denmark). These subsidiaries operate in the rapid diagnostics market through its Diagnostics business segment. The Diagnostics business segment offers a wide range of analytical instruments, reagents, consumables, software, and services to diagnose disease and make crucial treatment decisions and serves hospitals, physicians’ offices, reference laboratories, and other critical care settings.
The company has a presence in over 60 countries. The non-U.S. countries in which Danaher has a significant presence include China, Denmark, Germany, Singapore, Sweden, Switzerland, and the U.K. The manufacturing facilities of the Diagnostics business segment are located in North America, Europe, Asia, and Australia.
Thermo Fisher Scientific Inc. (U.S.)
Founded in 2006 and headquartered in Massachusetts, U.S., Thermo Fisher offers a wide range of healthcare technologies, software, and services. The company operates through four reportable business segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The company operates in the rapid diagnostics market through its Life Sciences Solutions and Specialty Diagnostics business segments. The Life Sciences Solutions business segment offers a wide range of reagents, instruments, and consumables used in biological and medical research, the discovery and production of new drugs and vaccines, and the diagnosis of infection and disease. The Specialty Diagnostics business segment offers a broad range of diagnostic test kits, reagents, instruments, culture media, and associated products used in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories.
Thermo Fisher has operations and a geographical presence in approximately 50 countries outside the U.S. The company has major manufacturing and distribution facilities worldwide, including in the U.S., Australia, Canada, China, Denmark, Finland, France, Germany, Japan, Singapore, Sweden, and the U.K. The company serves over 400,000 end customers working in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research & academic institutions, government firms, and environmental, industrial quality, and process control settings.
bioMérieux S.A. (France)
Founded in 1963 and headquartered in Marcy I’ Étoile, France, bioMérieux develops, manufactures, and markets in vitro diagnostic solutions. The company operates through two business segments, namely, Clinical Applications and Industrial Applications. The company operates in the rapid diagnostics market through its Clinical Applications segment. The Clinical Applications segment provides in-vitro diagnostic solutions that help doctors and healthcare workers to determine the source of disease. This segment is further categorized into microbiology, immunoassays, and molecular biology.
bioMérieux has a direct presence in 44 countries, and with a strong distribution network, the company serves more than 160 countries globally. The company has manufacturing sites for clinical solutions in the U.S., Canada, Japan, Brazil, and Australia.
Alfa Scientific Designs, Inc. (U.S.)
Founded in 1996 and headquartered in California, U.S., Alfa Scientific manufactures and markets rapid POC diagnostics devices used for screening drugs of abuse, fertility hormones, infectious diseases, cardiac and cancer markers, and other diagnostic areas. Alfa also offers product development and manufacturing services, including latex, lateral flow, fluorescent methodologies, OEM services, custom assay/device assembly, and packing with client-specific labeling. The company has also been granted 28 patents for its products and technologies.
BTNX Inc. (Canada)
Founded in 1998 and headquartered in Ontario, Canada, BTNX is a biotechnology company engaged in the manufacturing and marketing of rapid, point-of-care diagnostics devices for laboratories, clinics, hospitals, and physicians’ offices. BTNX also offers information technology systems to manage point-of-care diagnostic test results. The company has also received ISO 13485:2016 MDSAP certification for its manufacturing and quality systems. BTNX supplies its products in the rapid response category, which includes infectious disease tests, drug screening tests, cardiac markers, urinalysis tests, and fertility tests. The company is also a certified original equipment manufacturer (OEM) of rapid diagnostic tests.
Popular Mentions: Meridian Bioscience, Inc. (U.S.), and Trinity Biotech plc (Ireland)
